Skip to main content

SICK DAYS- SITUATIONS REQUIRING HOSPITALIZED CARE!

SITUATIONS REQUIRING HOSPITALIZED CARE

  • The NICE-SUGAR (Intensive versus conventional glucose in critically ill patients) trial compared intensive (81-108 mg/dL) with conventional glucose control using IV Insulin in 6104 intensive care unit patients.
  • At 90 days, intensively controlled patients had an increased absolute risk of death of 2.6%.
  • Significantly, more hypoglycemia was observed in intensively controlled group.

Recommendations:

  • Current recommendations call for critically ill patients to be started on IV Insulin therapy at a threshold of 180mg/dL.
  • A goal range of 140-180mg/dL is recommended for majority of patients.
  • More stringent goals may be considered for selected critically ill patients, but only if hypoglycemia can be avoided.
  • Scheduled SC insulin regimens with basal, nutritional and correction components are recommended for patients who are not critically ill.
  • Goals of less than 140mg/dL for fasting glucose and less than 180mg/dL for random glucose are recommended for non-critically ill patients.

  • Patients should monitor their blood glucose levels more frequently during the sick days because it is more common for illness to increase blood glucose values.
    • Patients with T1 DM should check their glucose and urine for ketones every 4 hours when sick.
    • Patients with T2 DM may also need to check for ketones when their blood glucose levels are greater than 300mg/dL.
    • Patients should continue to take their medications while sick.
    • T1 DM patients may require additional insulin coverage, and some with T2 DM who are currently on, or medication regimens may require insulin during an acute illness.
    • Patients should be advised to maintain their normal caloric intake and carbohydrate intake while ill as well as to drink plenty of non-caloric beverages to avoid dehydration.
    • When having difficulty eating a normal diet, patients may be advised to use non-diet beverages, soft drinks, broths, crackers, soup, and non-diet gelatins to provide normal caloric and carbohydrate intake and avoid hypoglycemia.
    • With proper management, patients can decrease their chances of illness-induced hospitalization, particularly Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State.

    Measurement of Blood Glucose Levels:

    Several methods can be used for measuring Blood glucose levels.

    • Arterial samples are usually 5mg/dL higher than capillary values and 10mg/greater than venous values.
    • When preparing an insulin infusion for a patient, several factors must be considered, insulin will absorb to glass and plastic, reducing the amount of insulin actually delivered by 20%-30%. Primarily, the tubing decreases the variability of insulin infused.
    • Therefore, when patients can be converted safely from infusion to needle and syringe therapy, the total daily dose should be reduced by 20%to 50% of the daily infusion amount.
    • When transferring someone from IV insulin drip to subcutaneous insulin, basal insulin should be administered several hours before the drip is discontinued to prevent loss of glycemic control.
    • IV drip protocols are institution specific.


    Labels:

    Comments

    Post a Comment

    Popular posts from this blog

    Procedure of IV selection!

     IV DRUG THERAPY- SELECTION OF EQUIPMENTS AND INSERTION OF CATHETER Equipment: Canula selection: Select cannula based on purpose and duration of use and age of patient. Consider risk of infection and extravasation. Cannula made from polyurethanes are associated with decreased risk of phlebitis. Steel needles have higher risk of extravasation and should be avoided where tissue necrosis is likely if extravasation occurs.       2. Skin Prep: Antiseptic solution, use an aqueous based alternative if there is a known allergy to alcohol.       3. Other Equipment: Intravenous solution as ordered, torniquet, giving set, IV stand/pole, infusion pump, transparent occlusive dressing, tape or similar to secure cannula, gloves, paper bag.       4. Additional Equipment which may be required: Syring (5mL), sterile sodium chloride 0.9%, local anesthetics (in children), 3-way tap or triflow, short extension tube. Selection Of the Catheter Site: Generally ...
    Post a Comment
    Read more

    Anatomy and the Complications Associated with Liver Diseases!

      LIVER AND THE COMPLICATIONS ASSOCIATED WITH THE PROGRESSION OF DISEASE! Liver: The liver weighs up to 1.5kg in adults and is the 2nd largest organ in the body. Hepatocytes are the functioning unit of liver. Impairment of liver may lead to: Acute liver diseases Chronic liver diseases Liver cirrhosis Acute Liver Disease (ALD): ALD is a self-limiting episode of hepatocyte damage which in most cases spontaneously without clinical sequelae, but acute liver failure (ALF) may develop. This is a rare condition in which there is a rapid deterioration in liver function with associated encephalopathy and coagulopathy. ALF carries significant morbidity and mortality and may require emergency liver transplant. Chronic Liver Disease (CLD): CLD occurs when the longstanding cell damage causes permanent structural changes within the liver, with the loss of normal liver structure and functions. In many cases, this may lead to cirrhosis where fibrosis sears divide the liver cells into areas of rege...
    Post a Comment
    Read more

    Myocardial Infarction- Etiology, Pathogenesis, Clinical Diagnosis and Management!

    MYOCARDIAL INFARCTION Definition: Myocardial Infarction is defined as " a diseased condition which is caused by reduced blood flow to the coronary artery due to atherosclerosis and occlusion of artery by embolus or thrombus." Myocardial Infarction (or Heart attack) is the irreversible damage of myocardial tissue due to prolonged ischemia or hypoxia. Universally accepted definition of MI:  Evidence of myocardial necrosis in consistent with the myocardial ischemia, in which case any of the following meets the diagnosis of Myocardial Infarction. Evidence rises and/or fall of cardiac biomarkers (preferably troponin). ECG changes indicative of new ischemia (new ST-T changes or new left bundle branch block) Development of pathological Q waves. Imaging evidence of new loss of viable myocardium or new regional wall motion abnormality. Etiology: Tobacco smoking Diabetes Mellitus Age Hypertension Obesity Gender Stress Drug abuse Alcohol consumption Family history of ischemic heart dise...
    Post a Comment
    Read more